Julie O'Neill - Jun 17, 2024 Form 4 Insider Report for HOOKIPA Pharma Inc. (HOOK)

Role
Director
Signature
/s/ Reinhard Kandera, Attorney-in-Fact
Stock symbol
HOOK
Transactions as of
Jun 17, 2024
Transactions value $
$0
Form type
4
Date filed
6/18/2024, 04:15 PM
Previous filing
Jun 9, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HOOK Stock Option (Right to Buy) Award $0 +49K $0.00 49K Jun 17, 2024 Common Stock 49K $0.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option award shall vest and become fully exercisable on the earlier to occur of (a) June 17, 2025 and (b) the date of the Issuer's next annual meeting of its stockholders.